The majority of these studies showed that the expression of lumican was abnormal; the cancer types studied included gastric cancer, colorectal cancer, pancreatic cancer, breast cancer, malignant melanoma, and other malignant tumor tissues. This evidence concerns the gene LUM and breast carcinoma.